PegBio Co Ltd

NEW
HKSE:02565 (China)   Ordinary Shares - Class H
HK$ 6.58 +1.255 (+23.59%) Aug 7
At Loss
P/B:
5.18
Market Cap:
HK$ 2.57B ($ 327.86M)
Enterprise V:
HK$ 2.04B ($ 260.43M)
Volume:
64.80M
Avg Vol (2M):
20.12M
Trade In:
Volume:
64.80M
At Loss
Avg Vol (2M):
20.12M

Business Description

Description
PegBio Co Ltd is engaged in the discovery and development of therapies. The company's main product PB-119, is a self-developed, obtained marketing approval from the National Medical Products Administration (NMPA) and entered commercialization preparation stage, long-acting glucagonlike peptide 1 (GLP-1, a peptide hormone that decreases blood sugar levels) receptor agonist. The Company's product candidates include PB-718, PB-1902, PB-722, PB-2301 and PB-2309.
Name Current Vs Industry Vs History
Cash-To-Debt
5.58
Equity-to-Asset
0.75
Debt-to-Equity
0.21
Debt-to-EBITDA
-0.46
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
12.2
3-Year EPS without NRI Growth Rate
12.6
3-Year FCF Growth Rate
3.5
3-Year Book Growth Rate
13.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
71.9
9-Day RSI
59.71
14-Day RSI
50.65
3-1 Month Momentum %
-77.8
6-1 Month Momentum %
-90.68
12-1 Month Momentum %
-62.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.94
Quick Ratio
3.94
Cash Ratio
3.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-0.4
Shareholder Yield %
-22.15
Name Current Vs Industry Vs History
ROE %
-82.79
ROA %
-52.3
ROIC %
-154.15
3-Year ROIIC %
128.56
ROC (Joel Greenblatt) %
-1914.98
ROCE %
-78.29

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio
5.18
Price-to-Tangible-Book
5.18
EV-to-EBIT
-9.03
EV-to-EBITDA
-9.13
EV-to-FCF
-11.95
Price-to-Net-Current-Asset-Value 5.72
Price-to-Net-Cash 6.26
Earnings Yield (Greenblatt) %
-11.07
FCF Yield %
-6.65

Financials

HKSE:02565's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

PegBio Co Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$)
EPS (TTM) (HK$) -0.604
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 181.15
14-Day RSI 50.65
14-Day ATR (HK$) 0.855611
20-Day SMA (HK$) 6.219
12-1 Month Momentum % -62.8
52-Week Range (HK$) 4.94 - 77
Shares Outstanding (Mil) 391.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PegBio Co Ltd Filings

Filing Date Document Date Form
No Filing Data

PegBio Co Ltd Stock Events

Financials Calendars
Event Date Price (HK$)
No Event Data

PegBio Co Ltd Frequently Asked Questions

What is PegBio Co Ltd(HKSE:02565)'s stock price today?
The current price of HKSE:02565 is HK$6.58. The 52 week high of HKSE:02565 is HK$77.00 and 52 week low is HK$4.94.
When is next earnings date of PegBio Co Ltd(HKSE:02565)?
The next earnings date of PegBio Co Ltd(HKSE:02565) is .
Does PegBio Co Ltd(HKSE:02565) pay dividends? If so, how much?
PegBio Co Ltd(HKSE:02565) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on PegBio Co Ltd

No articles.